Cite
HARVARD Citation
Sharma, D. et al. (2013). Role of Gefitinib in Patients With Recurrent or Metastatic Cervical Carcinoma Ineligible or Refractory to Systemic Chemotherapy: First Study From Asia. International journal of gynecological cancer. 23 (4), pp. 705-709. [Online].